阴腹膜透析剂是否与贝尼迪平的不良药物反应有关?
Yun Lin1, Shumin Huang2, Xiaorui Cai3
1Department of Pharmacy, Shantou Central Hospital, Shantou, Guangdong Province, China.
概括
贝尼迪平药物可以在腹腔透析 (PD) 患者中引起非传染性胆皮,导致透析液模糊. 这种药物不良反应,由升高的甘油三表示,需要仔细考虑,以避免误诊和不必要的治疗.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 药理学 药理学是指药理学的学科.
- 临床医学 临床医学
背景情况:
- 腹膜透析 (PD) 患者经常经历透析液模糊,这是腹膜炎的主要指标.
- 从临床上看,区分药物诱导的度与腹膜炎具有意义,但具有挑战性.
- 贝尼迪平通常用于PD患者的血压管理.
研究的目的:
- 在PD患者中调查贝尼迪平和非传染性胆皮之间潜在的联系.
- 描述与贝尼迪平诱导的透析液度相关的临床和实验室发现.
- 为了区分这种情况与传染性腹膜炎.
主要方法:
- 从2020年4月至2023年3月期间接受贝尼迪平治疗的287名PD患者的数据的回顾性分析.
- 监测透析液度和腹膜炎的临床症状.
- 透析液的实验室分析,包括甘油三水平,涂抹和培养物.
- 在切换抗高血压药物后评估变化.
主要成果:
- 25名患者 (8.71%) 发展出非传染性胆皮,这是对贝尼迪平的不良反应.
- 度发作发生在开始服用贝尼迪平后大约25天.
- 与透明透析剂 (0.07 ± 0.03 mmol/L) 相比,透透析剂显示出显著升高的甘油三水平 (0.28 ± 0.17 mmol/L) (p < 0.0001).
- 涂抹和培养对感染呈阴性,并且切换药物在12-36小时内消除了度.
结论:
- 贝尼迪平的使用是PD患者非传染性胆皮的潜在原因.
- 过高的透析三甘水平是这种情况的关键标志物.
- 对这种不良药物反应的认识对于预防腹膜炎的误诊和优化PD患者的抗高血压治疗至关重要.
相关概念视频
01:15Antihypertensive Drugs: Thiazide-Class Diuretics
538
Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
538
01:19Pharmacovigilance
773
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
773
01:20Desensitization and Tachyphylaxis
1.5K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.5K
01:28Antihypertensive Drugs: Potassium-Sparing Diuretics
448
Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
448
01:22Heart Failure Drugs: Diuretics
339
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
339
01:25Antianginal Drugs: Calcium Channel Blockers and Ranolazine
453
Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
453